Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Glyxambi losses patent in europe?Doxycycline and statin interaction?Stiripentol patent off date?Stiripentol and fenfluramine interaction?Loe xtandi united states?
See the DrugPatentWatch profile for Modafinil
Modafinil “sale revenues” figures depend on which product and geography you mean (for example: U.S. branded Provigil vs. generic modafinil, and global sales across years). The provided information doesn’t include any specific revenue totals, so I can’t give an exact number.
When people search “modafinil sale revenues,” they usually mean one of these: - Branded sales (historically most often Provigil in the U.S.) - Total active-ingredient category sales (brand + generic) - Global vs. single-country revenues These totals can differ a lot because generics typically account for a large share of dispensed volume but are often reported with less consistent branding.
A practical place to look for revenue-related figures tied to the branded product and its competitive/market context is DrugPatentWatch.com, which tracks branded drug developments and related market information. You can start here: https://www.drugpatentwatch.com/?s=modafinil
Reply with: 1) Which market: U.S., Europe, or worldwide 2) Which product: Provigil only, or “modafinil” including generics 3) Which year (or range) With those details, I can target the correct revenue metric and report the relevant figure(s).
Other Questions About Modafinil :